TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pfizer Anti-Infectives AB
Closing information (x1000 SEK)
Closing information | 2022/11 | 2021/11 | 2020/11 |
Turnover |
1,353,259
|
330,523
|
1,528,347 |
Financial expenses |
472
|
1,267
|
2 |
Earnings before taxes |
415,181
|
-567,244
|
1,222,069 |
EBITDA |
474,848
|
-506,783 | |
Total assets |
1,580,650
|
1,142,755
|
1,704,376 |
Current assets |
112,359
|
217,691
|
1,011 |
Current liabilities |
625,691
|
517,428
|
628,647 |
Equity capital |
954,959
|
625,327
|
1,075,729 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Solvency |
60.4%
|
54.7%
|
63.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.7%
|
-171.6%
|
80.0% |
Return on assets (ROA) |
26.3%
|
-49.5%
|
71.7% |
Current ratio |
18.0%
|
42.1%
|
0.2% |
Return on equity (ROE) |
43.5%
|
-90.7%
|
113.6% |
Change turnover |
1,022,736
|
-1,197,824
|
1,528,347 |
Change turnover % |
309%
|
-78% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.